BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27306938)

  • 1. Posterior Reversible Encephalopathy Syndrome in a Patient With Crohn's Disease on Infliximab.
    Chow S; Patnana S; Gupta NK
    J Clin Gastroenterol; 2016 Sep; 50(8):687. PubMed ID: 27306938
    [No Abstract]   [Full Text] [Related]  

  • 2. Psoriasiform Skin Lesions Are Caused by Both Infliximab and Adalimumab in a Patient with Crohn's Disease.
    Cankurtaran E; Ekiz F; Hamamci M; Akinci H; Coskun Y; Yuksel I
    Dig Dis Sci; 2016 Apr; 61(4):1206-7. PubMed ID: 26894400
    [No Abstract]   [Full Text] [Related]  

  • 3. A Case of Osteonecrosis of the Jaw in a Patient with Crohn's Disease Treated with Infliximab.
    Favia G; Tempesta A; Limongelli L; Crincoli V; Iannone F; Lapadula G; Maiorano E
    Am J Case Rep; 2017 Dec; 18():1351-1356. PubMed ID: 29257800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ileocolonic tuberculosis clinically, endoscopically, and radiologically mimicking Crohn's disease: disseminated infection after treatment with infliximab.
    Cappell MS; Saad A; Bortman JS; Amin M
    J Crohns Colitis; 2014 Jun; 8(6):560-2. PubMed ID: 24360259
    [No Abstract]   [Full Text] [Related]  

  • 5. Babesiosis in a patient on infliximab for Crohn's disease.
    Cullen G; Sands BE; Yajnik V
    Inflamm Bowel Dis; 2010 Aug; 16(8):1269-70. PubMed ID: 19885904
    [No Abstract]   [Full Text] [Related]  

  • 6. Cutaneous Pseudolymphoma in a Patient With Crohn's Disease Under Infliximab: First Report.
    Carvalhana S; Gonçalves A; Velosa J
    J Clin Gastroenterol; 2016; 50(5):436-7. PubMed ID: 26974759
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe sarcoidosis-like reaction in a patient with Crohn's Disease treated with infliximab. Any relationship?
    Fuentes-Valenzuela E; Navarro Cañadas C; Oyarzún Bahamonde E; Moreta Rodriguez M; Barrio J
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101696. PubMed ID: 33852954
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of posterior reversible encephalopathy syndrome in a child with Crohn's disease treated with Infliximab.
    Haddock R; Garrick V; Horrocks I; Russell RK
    J Crohns Colitis; 2011 Dec; 5(6):623-7. PubMed ID: 22115385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Unusual Cause of Skin Rash in Crohn's Disease.
    Chebli JMF; de Oliveira Moreira B; da Rocha Ribeiro TC
    Gastroenterology; 2018 Sep; 155(3):618-620. PubMed ID: 29409941
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pneumocystis jiroveci pneumonia following infliximab therapy in patient with Crohn's disease].
    Fluxá D; Segovia J; Florenzano M; Salinas J; Flores L; Simian D; Quera R
    Rev Chilena Infectol; 2017 Oct; 34(5):518-519. PubMed ID: 29488599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab-induced Liver Injury: A Common Link Between Crohn's Disease and Acute Liver Injury.
    Penrice DD; Kamboj AK; Simonetto DA
    Inflamm Bowel Dis; 2021 Jan; 27(1):e7-e8. PubMed ID: 32964222
    [No Abstract]   [Full Text] [Related]  

  • 12. Swift Efficacy with Infliximab 4 Years after Initial Standard Induction Therapy Followed by Severe Delayed Infusion Reaction in Crohn's Disease.
    Chiba M; Tsuji T; Nakane K; Obara Y; Komatsu M
    Inflamm Bowel Dis; 2020 Jan; 26(1):e4. PubMed ID: 31697829
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of Crohn's disease by infliximab. About 20 cases].
    Serghini M; Karoui S; Meknini M; Matri S; Kallel L; Fekih M; Boubaker J; Filali A
    Tunis Med; 2009 Sep; 87(9):579-82. PubMed ID: 20180377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large paraspinal abscess as a complication of infliximab therapy in Crohn's disease.
    Nithianandan N; Loftus MJ; Johnson PDR; Charles PGP
    BMJ Case Rep; 2019 Apr; 12(4):. PubMed ID: 31036734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab Drug-Induced Autoimmune Hepatitis in a Patient With Crohn's Ileocolitis.
    Karanfilian B; Mahpour N; Sarkar A
    Am J Ther; 2022 Nov-Dec 01; 29(6):e741-e743. PubMed ID: 33416253
    [No Abstract]   [Full Text] [Related]  

  • 16. Immortal time bias in estimates of mortality among infliximab-treated patients with Crohn's disease.
    Lewis JD
    Gut; 2010 Nov; 59(11):1586-7. PubMed ID: 20732919
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: treatment with subcutaneous CT-P13 in Crohn's disease patients with intravenous infliximab failure.
    Caron B; Fumery M; Netter P; Peyrin-Biroulet L
    Aliment Pharmacol Ther; 2022 Feb; 55(4):508-509. PubMed ID: 35092046
    [No Abstract]   [Full Text] [Related]  

  • 18. Interstitial pneumonitis after infliximab therapy for Crohn's disease.
    Weatherhead M; Masson S; Bourke SJ; Gunn MC; Burns GP
    Inflamm Bowel Dis; 2006 May; 12(5):427-8. PubMed ID: 16670533
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe agranulocytosis following first infliximab infusion in Crohn's disease.
    Rosales-Zábal JM; Fernández-Pérez F; Albandea-Moreno C; Vera-Rivero FM; Navarro-Jarabo JM
    Inflamm Bowel Dis; 2011 Nov; 17(11):E147-8. PubMed ID: 21830280
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe anaphylactic reaction to infliximab in pediatric patients with Crohn's disease.
    Diamanti A; Castro M; Papadatou B; Ferretti F; Gambarara M
    J Pediatr; 2002 May; 140(5):636-7; author reply 637. PubMed ID: 12032538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.